Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Sitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones. Concentrations of the active intact hormones are increased by JANUVIA, thereby increasing and prolonging the action of these hormones. Incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), are released by the intestine throughout the day, and levels are increased in response to a meal. These hormones are rapidly inactivated by the enzyme, DPP-4. The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells by intracellular signaling pathways involving cyclic AMP. GLP-1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production. By increasing and prolonging active incretin levels, JANUVIA increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. Sitagliptin demonstrates selectivity for DPP-4 and does not inhibit DPP-8 or DPP-9 activity in vitro at concentrations approximating those from therapeutic doses. 12.2 Pharmacodynamics General In patients with type 2 diabetes, administration of JANUVIA led to inhibition of DPP-4 enzyme activity for a 24-hour period. After an oral glucose load or a meal, this DPP-4 inhibition resulted in a 2- to 3-fold increase in circulating levels of active GLP-1 and GIP, decreased glucagon concentrations, and increased responsiveness of insulin release to glucose, resulting in higher C-peptide and insulin concentrations. The rise in insulin with the decrease in glucagon was associated with lower fasting glucose concentrations and reduced gluc
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:8/28/2014)... 28, 2014 Nonin Medical, Inc., the inventor ... medical monitoring, today announced that the Food and Drug ... finger pulse oximeter for use in the ... into a telemedicine hub or kiosk through a USB ... pediatric to adult patients. The Model 3231 received EU ...
(Date:8/28/2014)... Aug. 28, 2014   Edison Nation Medical ... a worldwide search for product ideas to improve ... Promising ideas uncovered through the 6-month search ( ... device manufacturers and healthcare retailers with whom Edison ... of individuals age 65 and older. ...
(Date:8/28/2014)... 28, 2014 The new ... Market (products, applications, techniques, end users and Geography) ... Forecast, 2013 - 2020," indicates that the global ... 2020 registering a CAGR of 9.8% from 2014 ... and cost effectiveness over alternative diagnostic techniques are ...
Breaking Medicine Technology:Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3
... Therapeutics (Nasdaq: NKTR ) will announce its financial ... Wednesday, April 27, 2011, after the close of U.S.-based financial ... a conference call to review the results beginning at 5:00 ... The press release and a live audio-only Webcast of ...
... processes happen in the blink of an eye – ... events virtually impossible. The advent of magnetoencephalography (MEG) changed ... measured in milliseconds, and offering the potential to reveal ... University of Technology is set to join the global ...
Cached Medicine Technology:Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets 2Australian Center Readies Brain Research Program for Addition of Elekta MEG System 2Australian Center Readies Brain Research Program for Addition of Elekta MEG System 3Australian Center Readies Brain Research Program for Addition of Elekta MEG System 4
(Date:8/28/2014)... (PRWEB) August 28, 2014 Commercial growers all ... new Kind K5 series LED grow lights, which perform on ... the wattage savings, Kind LED lighting needs no cooling equipment ... requires less cooling as well. Factoring in that they never ... lighting is less than a year. , For many indoor ...
(Date:8/28/2014)... 28, 2014 Following the death of an ... FDA issued a warning on powdered caffeine ... harmful substance that is readily available to consumers, despite the ... school senior Logan Stiner died from an overdose of caffeine ... leading the FDA to issue a safety advisory for caffeine ...
(Date:8/28/2014)... To kick off the fall season of sporting ... retailers across the country are offering 0% financing for ... Tub Tailgate Event is from August 29th-September 15th. ... and to apply early! , As the leader in ... of outdoor hot tubs with exclusive features at your ...
(Date:8/28/2014)... healthy volunteers in the UK, The Gambia and Mali ... of safety trials of potential vaccines aimed at preventing ... in the current outbreak in West Africa. , Human ... US National Institutes of Health (NIH) and GlaxoSmithKline, are ... in response to the Ebola epidemic, which the World ...
(Date:8/28/2014)... 2014) A fortuitous collaboration at Rice University ... recently discovered natural antibiotic. , The laboratory recreation ... help bolster the fight against bacteria that evolve ... the world. , As part of the ... biologist Yousif Shamoo and their colleagues created and ...
Breaking Medicine News(10 mins):Health News:New Kind K5 Series LED Grow Lights Pave Way for Future of Indoor Gardening 2Health News:FDA Issues Safety Advisory for Caffeine Powders 2Health News:Ebola vaccine trials fast-tracked by international consortium 2Health News:Ebola vaccine trials fast-tracked by international consortium 3Health News:Ebola vaccine trials fast-tracked by international consortium 4Health News:Synthesis produces new antibiotic 2Health News:Synthesis produces new antibiotic 3Health News:Synthesis produces new antibiotic 4
... Geffen School of Medicine and the Henry Samueli School of ... have successfully// transformed adult stem cells taken from human adipose, ... normal function of a large number of organs like the ... their study might help lead to the use of fat ...
... A new approach to detecting cancer has recently been ... detect cancer cells of many malignancies before// they turn ... that they have applied this technique to detect leukemia ... approach to diagnosing cancer at the molecular level." This ...
... to a study conducted by the researchers at the ... diet in pregnancy influences the child's susceptibility to atherosclerosis. ... children and correlated that the lower the mother's calorific ... The researchers used ultrasound scans to measure the thickness ...
... time high in the United Kingdom, and space sensors have ... levels. //According to the Met office reports, during the period ... high in UK along with nitrogen dioxide pollution, which is ... ,These facts are dramatically demonstrated by the latest images ...
... cases of malaria are reported each year. However, a ... Leeds, //with funding from the Bill & Melinda Gates ... from the disease. ,Design lecturer Dr Stephen ... at the Roslin Biocentre will develop a precisely engineered ...
... which environmental stimulation decelerates Alzheimer's disease, further affirming ... decline. ,A paper to this effect ... amyloid angiopathy and A? plaque burden after enriched ... appears in the2006 August issue of The American ...
Cached Medicine News:Health News:UCLA Researchers Transform Stem cells From Fat tissues Into Smooth Muscle 2Health News:UCLA Researchers Transform Stem cells From Fat tissues Into Smooth Muscle 3Health News:New Technique To Diagnose Cancer At Molecular Level 2Health News:Sensor Images Show Soaring Temperature and Pollution Levels in UK 2Health News:Revolutionary Net To Control Malaria 2Health News:Active Life Decelerates Alzheimer's 2
For Atrial Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The CRISTA CATH 20-pole deflectable catheter is designed for positioning along the crista terminals....
... Inquiry H Steerable Catheter. Steerable ... variety of designs and a ... stability. 10 to 24 electrodes, ... inactive and active tip electrodes, ...
Sophisticated DecaPolar Catheters provide enhanced recording and mapping quality....
... Torqr Quadripolar Braided Shaft ... The Medtronic CardioRhythm Torqr ... use in diagnostic electrophysiologic ... designed for recording intracardiac ...
Medicine Products: